Question 1

What is Marnix Jansen?

Accepted Answer

Marnix Jansen is a Person.

Question 2

How often does Marnix Jansen appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Marnix Jansen first tracked by Ergen?

Accepted Answer

First tracked on Apr 20, 2026.

Question 4

When was Marnix Jansen last mentioned in news?

Accepted Answer

Last active on May 14, 2026.

Question 5

What is Marnix Jansen's current news sentiment?

Accepted Answer

Aggregate sentiment score: 50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Marnix Jansen in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Marnix Jansen?

Accepted Answer

Immunotherapy Improves Bowel Cancer Survival (Apr 20, 2026, 6 articles).

Question 8

How did the "Immunotherapy Improves Bowel Cancer Survival" event impact Marnix Jansen?

Accepted Answer

Marnix Jansen is a clinician scientist and consultant histopathologist leading the translational research on the NEOPRISM-CRC trial from the University College London Cancer Institute and University College London Hospitals NHS Foundation Trust.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.